Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 2101 to 2150 of 2529

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liverHTG291
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancerTA263
Mega Soft Patient Return Electrode for use during monopolar electrosurgeryHTG290
Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolismTA261
Endovascular stent insertion for intracranial atherosclerotic diseaseHTG288
Partial replacement of the meniscus of the knee using a biodegradable scaffoldHTG289
Sickle cell disease: managing acute painful episodes in hospitalCG143
Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer that overexpresses HER2TA257
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancerTA258
Botulinum toxin type A for the prevention of headaches in adults with chronic migraineTA260
Percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillationHTG286
Focal therapy using cryoablation for localised prostate cancerHTG284
Micropressure therapy for refractory Ménière's diseaseHTG285
Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosisTA254
Incisionless otoplastyHTG283
Tocilizumab for the treatment of rheumatoid arthritisTA247
Rituximab for the first-line treatment of stage III-IV follicular lymphomaTA243
Apixaban for preventing venous thromboembolism after hip or knee replacement surgeryTA245
Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapyTA242
Breast reconstruction using lipomodelling after breast cancer treatmentHTG280
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancerTA118
Epiretinal brachytherapy for wet age-related macular degenerationHTG279
Service user experience in adult mental health: improving the experience of care for people using adult NHS mental health servicesCG136
Tocilizumab for the treatment of systemic juvenile idiopathic arthritisTA238
Fulvestrant for the treatment of locally advanced or metastatic breast cancerTA239
Drainage, irrigation and fibrinolytic therapy (DRIFT) for post-haemorrhagic hydrocephalus in preterm infantsHTG276
Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroidsHTG277
Single-port laparoscopic nephrectomyHTG278
Healthcare-associated infections: prevention and controlPH36
The EOS 2D/3D imaging systemHTG274
Mifamurtide for the treatment of osteosarcomaTA235
Ticagrelor for the treatment of acute coronary syndromesTA236
Minimally invasive oesophagectomyHTG272
Arthroscopic femoro–acetabular surgery for hip impingement syndromeHTG273
Laparoscopic cryotherapy for renal cancerHTG271
Agomelatine for the treatment of major depressive episodes (terminated appraisal)TA231
Bortezomib and thalidomide for the first‑line treatment of multiple myelomaTA228
Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusionTA229
Percutaneous cryotherapy for renal cancerHTG269
Open femoro–acetabular surgery for hip impingement syndromeHTG270
Ambulight PDT for the treatment of non-melanoma skin cancerHTG268
The MIST Therapy system for the promotion of wound healingHTG267
Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarctionTA73
Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancerTA227
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugsTA225
Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphomaTA226
Endoscopic radical inguinal lymphadenectomyHTG265
Thoracoscopic exclusion of the left atrial appendage (with or without surgical ablation) for non-valvular atrial fibrillation for the prevention of thromboembolismHTG266
Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial diseaseTA223
Endoscopic radiofrequency therapy of the anal sphincter for faecal incontinenceHTG262

Results per page

  1. 10
  2. 25
  3. 50
  4. All